Answers are grounded in this paper and cite their sources.
To develop a methodology to reduce the impact of pseudoexacerbations on annualized relapse rates in the ULTIMATE trials.
No takes yet. Share an insight, caveat, or question.
Krieger et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: